IMAP Brazil (Brasilpar) is pleased to announce that Zoetis, the largest animal health company worldwide, sold its 144,000 m2 pharmaceutical plant in Guarulhos, São Paulo, to Brazilian pharmaceutical company União Química. The transaction also involved a manufacturing and supply agreement between the parties, according to which União Química will be responsible for the manufacturing of Zoetis’ products.
Zoetis (NYSE: ZTS) – Global leader in animal health, present in more than 100 countries, with approximately 9 thousand employees and revenues of US$ 4.9 billion in 2016. The Brazilian market is the main international operation of Zoetis, representing 5% of its total revenues.
União Química – Company with more than 80 years of tradition in the Brazilian market, among the ten largest Brazilian pharmaceutical companies and leader in the manufacturing of pharmaceutical products for third parties.
The International Finance Corporation (IFC), a member of the World Bank Group, is investing $10 million in Egyptian company Globatronics
Based at the IMAP office in Munich, Ruta will be responsible for national and international buy-side and sell-side mandates within the healthcare sector, focusing on medium-sized companies.
Begra Group annually equips over 15,000 warehouses of various sizes with new and used warehouse racking and related materials.
